ResearcherFirst Affiliated Hospital of Zhengzhou UniversityNo recent work listed

Feng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5205-871X; OpenAlex author ID A5100778800. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma. Last author DOI 10.1097/md.0000000000032976 ↗
Comprehensive Analysis of the Prognosis of S100 Family Members and Their Relationship with Tumor-Infiltrating Immune Cells in Human Pancreatic Adenocarcinoma Last author DOI 10.21203/rs.3.rs-841869/v2 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yajun Ren · 2 shared papers, 2022–2023 · strength 0.49
- Paper Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune ce… DOI 10.1097/md.0000000000032976 ↗
- Paper Comprehensive Analysis of the Prognosis of S100 Family Members and Their Relationship with Tumor-Infiltrating Immune Ce… DOI 10.21203/rs.3.rs-841869/v2 ↗
Bing Chen Ma · 1 shared paper, 2023 · strength 0.26
- Paper Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune ce… DOI 10.1097/md.0000000000032976 ↗
Bing Chen · 1 shared paper, 2022 · strength 0.22
- Paper Comprehensive Analysis of the Prognosis of S100 Family Members and Their Relationship with Tumor-Infiltrating Immune Ce… DOI 10.21203/rs.3.rs-841869/v2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.